Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis : a case report

Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal side-effect of antipsychotic drug therapy, especially of dopamine receptor antagonists. As a dose relationship has been postulated, low dose neuroleptization would be expected to help to avoid this side-effect. In contrast, we repo...

Ausführliche Beschreibung